Mutations in the COCH gene are a frequent cause of autosomal dominant progressive cochleo-vestibular dysfunction, but not of Meniere's disease

• Published in: European journal of human genetics : EJHG Vol. 11; no. 10; pp. 744 - 748
• Main Authors: Usami, Shin-ichi, Takahashi, Kentaro, Yuge, Isamu, Ohtsuka, Akihiro, Namba, Atsushi, Abe, Satoko, Fransen, Erik, Patthy, Laszlo, Otting, Gottfried, Van Camp, Guy
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 01-10-2003
• Subjects: Adult; Deafness - genetics; DNA Mutational Analysis; Exons; Extracellular Matrix Proteins; Genes, Dominant; Genetics; Hearing; Hearing loss; Hearing Loss, Sensorineural - genetics; Hearing protection; Humans; Japan; Medicine; Meniere Disease - genetics; Meniere's disease; Middle Aged; Missense mutation; Models, Molecular; Mutation; Otolaryngology; Pedigree; Point Mutation; Population studies; Protein Binding; Protein Structure, Tertiary; Proteins; Proteins - genetics; Spatial discrimination; Vertigo - genetics; Vestibular Diseases - genetics; Vestibular system; Japan; Netherlands; Belgium; United States > US
• ISSN: 1018-4813; 1476-5438
• DOI: 10.1038/sj.ejhg.5201043

The COCH gene is the only gene identified in man that causes autosomal dominantly inherited hearing loss associated with vestibular dysfunction. The condition is rare and only five mutations have been reported worldwide. All affected families showed a similar progressive hearing loss and vestibular dysfunction. Since Meniere's disease-like symptoms have also been described in some families, it was suggested that COCH mutations might be present in some patients diagnosed with Meniere's disease. In this study, using a Japanese population, we performed a COCH mutation analysis in 23 patients from independent families with autosomal dominant hearing impairment, four of whom reported vestibular symptoms, and also in 20 Meniere's patients. While a new point mutation, A119 T, was found in a patient with autosomal dominant hearing loss and vestibular symptoms, no mutations were found in the Meniere's patients. Like all other previously identified COCH mutations, the mutation identified here is a missense mutation located in the FCH domain of the protein. The current mutation is located in close spatial proximity to W117, in which a mutation (W117R) had previously been associated with autosomal dominant hearing loss. Model building suggests that, like the W117R mutation, the A119 T mutation does not affect the structural integrity of the FCH domain, but may interfere with the interaction with a yet unknown binding partner. We conclude that mutations in the COCH gene are responsible for a significant fraction of patients with autosomal dominantly inherited hearing loss accompanied by vestibular symptoms, but not for dominant hearing loss without vestibular dysfunction, or sporadic Meniere's disease.